SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549



FORM 8-K/A
 


CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported):  August 12, 2011
 


Quest Diagnostics Incorporated
(Exact Name of Registrant as Specified in Its Charter)
 


Delaware
(State or other jurisdiction of Incorporation)

     
001-12215
 
16-1387862
(Commission File Number)
 
 
(I.R.S. Employer Identification No.)
Three Giralda Farms
Madison, NJ  07940
 
07940
(Address of principal executive offices)
 
(Zip Code)
     
(973) 520-2700
(Registrant’s telephone number, including area code)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction a.2. below):
 
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 


 
 
 
 
     
Explanatory Note
 
This Form 8-K/A is being filed as an amendment (“Amendment No. 1”) to the current report on Form 8-K filed by Quest Diagnostics Incorporated (the “Company”) with the Securities and Exchange Commission on May 20, 2011 (the “Original Filing”).  The sole purpose of this Amendment No. 1 is to disclose the Company’s decision regarding how frequently it will conduct stockholder advisory votes on executive compensation.  No other changes have been made to the Original Filing.

Item 5.07.  Submission of Matters to a Vote of Security Holders
 
In light of the voting results concerning the frequency with which stockholders will be provided an advisory vote on executive compensation that were delivered at the Company’s 2011 annual meeting of stockholders, the Company’s board of directors has determined that the Company will hold an annual advisory vote on executive compensation until the next vote on the frequency of stockholder votes on executive compensation. The Company is required to hold votes on frequency not less frequently than every six years.
 
 
 
 
 
 
 
 
 
 
 

 
 
Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
   
  August 17, 2011  
     
  QUEST DIAGNOSTICS INCORPORATED  
         
         
  By:   /s/ William J. O’Shaughnessy, Jr.  
      William J. O’Shaughnessy, Jr.  
      Assistant General Counsel and
Secretary